Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.
Journal article
EMPA-KIDNEY Collaborative Group None., (2022), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.
Other
Ng SYA. et al, (2020), Nephrol Dial Transplant
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
Journal article
Ai Ng SY. et al, (2020), Ann Intern Med, 172
Renal failure and its treatment
Journal article
Ng S. and Hanison J., (2018), Anaesthesia & Intensive Care Medicine, 19, 217 - 223
Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing
Journal article
Cuthbertson DJ. et al, (2016), Diabetic Medicine, 33, 1052 - 1059
Liraglutide in the treatment of obesity
Journal article
Ng SYA. and Wilding JPH., (2014), Expert Opinion on Biological Therapy, 14, 1215 - 1224